TGFB1 and neoplasm: Jiang L. et al. reported that in gastric cancer, SERPINA1 can regulate TGF-β signaling pathway to accelerate the growth and progression of tumor, indicating that SERPINA1 may be a novel candidate therapeutic target [36].